Deficient IgA and IgG2 anti-pneumococcal antibody levels and response to vaccination in otitis prone children

被引:24
作者
Dhooge, IJ
van Kempen, MJP
Sanders, LAM
Rijkers, GT
机构
[1] State Univ Ghent Hosp, Dept Otolaryngol, B-9000 Ghent, Belgium
[2] Univ Med Ctr, Wilhelmina Childrens Hosp, Dept Pediat Immunol, Utrecht, Netherlands
关键词
Streptococcus pneumoniae; recurrent acute otitis media; immunization; polysaccharide vaccine; IgG2-IgA antibodies;
D O I
10.1016/S0165-5876(02)00068-X
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: To evaluate the isotype and IgG subclass distribution of anti-pneumococcal antibodies and response to polysaccharide vaccination in otitis prone children. Methods: IgG1, IgG2 and IgA antibodies to pneumococcal serotypes 3, 4, 6B, 9V, 14, 19F and 23F were determined in otitis prone children and in an age-matched healthy control population. Patients were immunized with a 23-valent pneumococcal polysaccharide vaccine. The antibody response was measured 4 weeks later. Results: Geometric mean IgA and IgG2 antibody levels for all seven pneumococcal serotypes tested were significantly lower in otitis prone children than in the control population. After immunization, there was no significant increase in geometric mean IgG2 anti-serotype 6B, 19F and 23F pneumococcal polysaccharide (weak immunogenic), but also no increase for IgG2 anti-serotype 4 and 14. Post immunization IgG2 antibody titers for serotypes 6B, 9V and 19F even remained below titers of non-vaccinated controls. Nine out of 29 otitis prone children were colonized nasopharyngeally with Streptococcus pneumoniae during the time of vaccination; these children had an even more severely impaired systemic antibody response. Conclusions: Otitis prone children, while having normal IgGl antibody levels, have low IgG2 and IgA anti-polysaccharide antibody levels and fail to respond in these subclasses upon vaccination with pneumococcal polysaccharide vaccine. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:133 / 141
页数:9
相关论文
共 34 条
[1]   WHAT IS AN OTITIS-PRONE CHILD [J].
ALHO, OP ;
KOIVU, M ;
SORRI, M .
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 1991, 21 (03) :201-209
[2]   IMMUNOGLOBULIN-G, TOTAL AND SUBCLASS, IN CHILDREN WITH OR WITHOUT RECURRENT OTITIS-MEDIA [J].
BERMAN, S ;
LEE, B ;
NUSS, R ;
ROARK, R ;
GICLAS, PC .
JOURNAL OF PEDIATRICS, 1992, 121 (02) :249-251
[3]   Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children [J].
Black, S ;
Shinefield, H ;
Fireman, B ;
Lewis, E ;
Ray, P ;
Hansen, JR ;
Elvin, L ;
Ensor, KM ;
Hackell, J ;
Siber, G ;
Malinoski, F ;
Madore, D ;
Chang, I ;
Kohberger, R ;
Watson, W ;
Austrian, R ;
Edwards, K .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) :187-195
[4]  
BLOEM AC, 1988, J IMMUNOL, V140, P768
[5]   10-YEAR REVIEW OF OTITIS-MEDIA PATHOGENS [J].
BLUESTONE, CD ;
STEPHENSON, JS ;
MARTIN, LM .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (08) :S7-S11
[6]   Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta [J].
Breukels, MA ;
Rijkers, GT ;
Voorhorst-Ogink, MM ;
Zegers, BJM ;
Sanders, LAM .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (05) :1152-1156
[7]   Pneumococcal conjugate vaccines overcome splenic dependency of antibody response to pneumococcal polysaccharides [J].
Breukels, MA ;
Zandvoort, A ;
van den Dobbelsteen, GPJM ;
van den Muijsenberg, A ;
Lodewijk, ME ;
Beurret, M ;
Klok, PA ;
Timens, W ;
Rijkers, GT .
INFECTION AND IMMUNITY, 2001, 69 (12) :7583-7587
[8]   Epidemiology of pneumococcal serotypes and conjugate vaccine formulations [J].
Butler, JC .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1997, 3 (02) :125-129
[9]   Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine [J].
Dagan, R ;
Melamed, R ;
Muallem, M ;
Piglansky, L ;
Greenberg, D ;
Abramson, O ;
Mendelman, PM ;
Bohidar, N ;
Yagupsky, P .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) :1271-1278
[10]  
Dhooge Ingeborg, 1999, Clin Microbiol Infect, V5, P530, DOI 10.1111/j.1469-0691.1999.tb00430.x